Nuechterlein Carole 4
4 · Entrada Therapeutics, Inc. · Filed Nov 1, 2021
Insider Transaction Report
Form 4
Nuechterlein Carole
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-10-28+23,552→ 23,522 totalExercise: $20.00Exp: 2031-10-28→ Common stock (23,552 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 36 equal monthly installments, commencing on October 28, 2021 (the "Vesting Start Date"), such that the option shares shall be fully vested on the three-year anniversary of the Vesting Start Date.